Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03907852 |
Title | Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | TCR2 Therapeutics |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California, San Francisco | San Francisco | California | 94143 | United States | Details | |
University of Miami Sylvester Cancer Center | Miami | Florida | 33136 | United States | Details | |
University of Chicago Medical Center | Chicago | Illinois | 60637 | United States | Details | |
National Cancer Institute | Bethesda | Maryland | 20814 | United States | Details | |
Columbia University Medical Center | New York | New York | 10032 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Duke University | Durham | North Carolina | 27705 | United States | Details | |
University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details | |
SCRI Oncology Partners | Nashville | Tennessee | 37203 | United States | Details | |
University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Princess Margaret Cancer Centre | Toronto | Ontario | M5G 2C1 | Canada | Details |